UnitedHealth Group Incorporated filings document the formal disclosures of a large health care company organized around UnitedHealthcare and Optum. Proxy materials describe board governance, executive compensation, shareholder voting matters and the company’s complementary businesses: UnitedHealthcare health coverage and Optum clinical, data, product, pharmacy and care services.
Current reports on Form 8-K cover operating and financial results, Regulation FD communications, strategy and market-position discussions, director appointments, compensation arrangements and other material-event disclosures. The filing record also documents governance practices, capital-structure and compensation matters, risk-related business context and the regulatory reporting framework for a Delaware public operating company in the health care sector.
UnitedHealth Group director reports receipt of dividend equivalents in stock. A director of UnitedHealth Group Inc. received 11 shares of common stock on 12/16/2025 at a reported price of $0. The filing explains that these shares represent dividend equivalents paid on vested deferred stock units, and that the dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. Following this transaction, the director beneficially owns 1,527 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group CEO and director Stephen J. Hemsley reported a routine insider transaction involving dividend equivalents on his deferred stock units. On 12/16/2025, he acquired 52 shares of common stock at a price of $0, reflecting dividend equivalents that are immediately vested and subject to the same terms as the underlying deferred stock units.
Following this transaction, Hemsley beneficially owns 427,947.942 shares of UnitedHealth Group common stock directly. He also reports indirect ownership of 351.9396 shares through a 401(k) and 681,875 shares through trusts. The filing reflects an incremental increase tied to existing equity compensation rather than an open-market purchase.
UnitedHealth Group director reports small stock accrual from dividends
A UnitedHealth Group Inc. director, Frederick William McNabb III, reported receiving 53 shares of UnitedHealth Group common stock on 12/16/2025. The filing states these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. The transaction was recorded at a price of $0 per share, reflecting that no cash was paid by the director for these shares.
Following this transaction, the director beneficially owns 14,394 shares of UnitedHealth Group common stock in direct ownership. The form was filed as a single-reporting-person Form 4 and signed by an attorney-in-fact on behalf of the director.
UnitedHealth Group director John H. Noseworthy, M.D. reported a small increase in his holdings of UnitedHealth Group common stock. On 12/16/2025, he acquired 43 shares at a price of $0, described as dividend equivalents paid on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units. Following this transaction, he beneficially owns 6,736 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director Kristen L. Gil reported a small change in her holdings of UnitedHealth Group common stock. On 12/16/2025, she acquired 7 shares of common stock at a price of $0, recorded as dividend equivalents paid on vested deferred stock units. After this transaction, she beneficially owned 1,907 shares directly and 3,800 shares indirectly through a trust. The dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.
UnitedHealth Group executive Christopher R. Zaetta, EVP & Chief Legal Officer, reported acquiring additional UnitedHealth Group common stock through dividend equivalents on restricted stock units. On 12/16/2025, he acquired 44.528 shares at a price of $0, reflecting reinvested dividends rather than an open-market purchase. These dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and are forfeited if those units do not vest. Following this transaction, Zaetta beneficially owns 10,327.804 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group insider Patrick H. Conway, Chief Executive Officer of Optum, reported an increase in his holdings of company common stock through dividend equivalents on restricted stock units. On 12/16/2025, he acquired 67.721 shares at a price of $0, reflecting stock dividends credited on his outstanding restricted stock units. After this transaction, he beneficially owned 10,603.915 shares of UnitedHealth Group common stock in direct ownership. The filing notes that these dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest.
UnitedHealth Group reported an insider equity update for its Chief Financial Officer. On 12/16/2025, the CFO acquired 70.042 shares of UnitedHealth Group common stock at a price of $0. These shares represent dividend equivalents credited on outstanding restricted stock units, meaning additional shares were granted in lieu of cash dividends on those units.
Following this transaction, the CFO beneficially owns 10,661.941 shares of UnitedHealth Group common stock in direct ownership. The dividend-equivalent shares are subject to the same vesting and forfeiture conditions as the underlying restricted stock units.
UnitedHealth Group Inc. director Timothy P. Flynn reported a small increase in his holdings of the company’s common stock through an insider transaction dated 12/16/2025. The filing shows an acquisition of 65 shares of common stock at a stated price of $0, described as dividend equivalents paid on vested deferred stock units that are immediately vested and follow the same terms as the underlying units.
After this transaction, Flynn beneficially owned 9,875 shares of UnitedHealth Group common stock directly and 6,033 shares indirectly through a trust. The form is filed for one reporting person and is signed by an attorney-in-fact on Flynn’s behalf.
UnitedHealth Group director reports additional stock via dividend equivalents. Director Michele J. Hooper reported acquiring 249 shares of UnitedHealth Group common stock on 12/16/2025 at a price of $0 per share. These shares represent dividend equivalents paid on vested deferred stock units and are immediately vested, carrying the same terms as the underlying deferred stock units. Following this transaction, she beneficially owns 41,126 shares of UnitedHealth Group common stock in direct ownership.